Stocktoria
Olympus Corporation 7733.T
JP · Tokyo Stock Exchange · XTKS · stock · Healthcare · website
Olympus Corporation financials (annual)
Bars are annual figures from 2023 to 2026; red bars are negative (a loss or cash outflow).
| Metric | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Revenue | ¥1.01T | ¥997.3B | ¥925.8B | ¥881.9B |
| Gross profit | ¥654.1B | ¥683.7B | ¥618.4B | ¥596.8B |
| SG&A expense | ¥507.1B | ¥495.7B | ¥466.8B | ¥420.5B |
| Operating income | ¥100.8B | ¥162.0B | ¥51.7B | ¥186.1B |
| Interest expense | ¥9.3B | ¥6.8B | ¥10.3B | ¥8.2B |
| Income tax | ¥25.8B | ¥41.3B | ¥8.5B | ¥44.3B |
| Net income | ¥68.2B | ¥117.9B | ¥242.6B | ¥143.4B |
| EPS (diluted) | — | ¥102.80 | ¥199.44 | ¥113.08 |
| Operating cash flow | ¥100.6B | ¥190.5B | ¥42.4B | ¥98.5B |
| Free cash flow | ¥18.2B | ¥125.3B | -¥22.3B | ¥27.9B |
| Cash & equivalents | ¥188.0B | ¥252.5B | ¥340.9B | ¥169.3B |
| Inventory | ¥207.1B | ¥187.1B | ¥190.0B | ¥163.0B |
| Goodwill | ¥194.2B | ¥180.6B | ¥180.3B | ¥181.3B |
| Total assets | ¥1.54T | ¥1.43T | ¥1.53T | ¥1.51T |
| Total debt | ¥239.6B | ¥229.1B | ¥299.6B | ¥340.1B |
| Total liabilities | ¥725.1B | ¥681.5B | ¥777.0B | ¥867.5B |
| Shareholders' equity | ¥812.0B | ¥751.7B | ¥757.2B | ¥640.1B |
| Share buybacks | ¥50.0B | ¥100.0B | ¥180.0B | ¥50.0B |
Growth · year-over-year · Revenue CAGR 4.6%
| Metric | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Revenue growth | +1.3% | +7.7% | +5.0% | — |
| Net income growth | -42.2% | -51.4% | +69.1% | — |
| EPS growth | — | -48.5% | +76.4% | — |
| Free cash flow growth | -85.5% | — | -179.9% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · JP · as of 2026-03-31. Figures in JPY. Facts plus Stocktoria's own computed scores — not investment advice.